The process for drug registration in China involves submitting an application to the National Medical Products Administration (NMPA). This includes clinical trial data, safety and efficacy evaluations, manufacturing information, and product specifications. After rigorous review, if approved, the drug can be marketed and distributed in China. Constant monitoring ensures safety and efficacy post-approval.
